Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-09-005618
Filing Date
2009-02-06
Accepted
2009-02-05 20:20:54
Documents
3
Period of Report
2009-02-05

Document Format Files

Seq Description Document Type Size
1 v138977_6-k.htm 6-K 146312
2 GRAPHIC logo1.jpg GRAPHIC 19050
3 GRAPHIC logo2.jpg GRAPHIC 31930
  Complete submission text file 0001144204-09-005618.txt   218238
Mailing Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989
Business Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989 972-8-930-4440
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 000-51310 | Film No.: 09574470
SIC: 2834 Pharmaceutical Preparations